Български
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)

Association Between Maternal Metabolic Disturbances During the First Pregnancy and Breast Density

Само регистрирани потребители могат да превеждат статии
Вход / Регистрация
Линкът е запазен в клипборда
СъстояниеНабиране
Спонсори
Instituto de Nutrición y Tecnología de los Alimentos
Сътрудници
Pontificia Universidad Catolica de Chile
Servicio de Salud Metropolitano Sur Oriente

Ключови думи

Резюме

Background. Breast cancer (BC) is the leading cause of cancer-related mortality in Chilean women. Mammographic density (BD) refers to the percentage of dense tissue of an entire breast. A high BD is the strongest known risk factor for BC. BD is partially modifiable; the first full term pregnancy (FFTP) reduces BD by average 12%. However, half of the women have no changes in BD after their FFTP and there is no evidence about factors that influence this lack of reduction. Identifying women who do not reduce BD after their FFTP and the potential factors associated with this lack of reduction would help to recognize a subgroup of women with greater vulnerability to BC. In some women, such as obese pregnant women of women with gestational diabetes (GDM), the metabolic adaptations are exaggerated and they show a disturbed metabolic milieu (characterized by hyperinsulinemia, hyperglycemia, higher C-reactive protein levels, and lower level of sex hormone-binding globulin), which may have biological effects on breast composition during this period of breast differentiation. Hypothesis. The hypothesis of the study proposes that the women with an altered metabolic milieu during their first full-term pregnancy will have higher breast density measured through DXA three months after cessation of lactation, when fully breast involution after pregnancy is achieved, compared to women without metabolic disturbances during their first full-term pregnancy. General Objective. The main goal is to evaluate in a cohort of primipara women the association between an altered metabolic milieu during pregnancy and breast density measured by DXA three months after breastfeeding cessation. Methods. One thousand pregnant women will be recruited at the beginning of their first pregnancy and evaluated at <15, 24-38 and 35-37 weeks during pregnancy and three months after breastfeeding cessation, as part of a longitudinal study. The main outcome will be breast composition measures three months after breastfeeding cessation. The main predictor will be metabolic status during pregnancy. Three months after breastfeeding cessation will record delivery data and a breast DXA exam will be carried out. Multiple linear regression models and generalized estimated equations will be used to explain this relationship. Expected results. The ultimate goal is to provide evidence on how to prevent breast cancer risk by reducing breast density.

Дати

Последна проверка: 07/31/2019
Първо изпратено: 04/15/2019
Очаквано записване подадено: 04/15/2019
Първо публикувано: 04/17/2019
Изпратена последна актуализация: 08/07/2019
Последна актуализация публикувана: 08/08/2019
Действителна начална дата на проучването: 06/30/2019
Приблизителна дата на първично завършване: 04/30/2022
Очаквана дата на завършване на проучването: 03/31/2023

Състояние или заболяване

Breast Density

Интервенция / лечение

Other: Primipara pregnant women

Фаза

-

Групи за ръце

ArmИнтервенция / лечение
Primipara pregnant women
Primipara pregnant women
Other: Primipara pregnant women
The altered metabolic milieu is defined as a fasting glucose level >100 mg/dL at the first trimester of pregnancy by national guidelines. Altered metabolic milieu during the second trimester (24-28 weeks of pregnancy) is defined as a fasting glucose levels > 92 mg/dL and/or plasma glucose levels > 153 mg/dL two hours afterload in the oral glucose tolerance test according to ADA guidelines or a fasting glucose >100 mg/dL and/or > 140 mg/dL two hours afterload in the oral glucose tolerance test according to national guidelines.

Критерии за допустимост

Възрасти, отговарящи на условията за проучване 18 Years Да се 18 Years
Полове, допустими за проучванеFemale
Метод за вземане на пробиProbability Sample
Приема здрави доброволциДа
Критерии

Inclusion Criteria:

- Primipara (no previous pregnancies)

- 18 to 25 years of age

- Gestation <15 weeks at first prenatal visit

- No intention to move outside the city of Santiago in the next to years

Exclusion Criteria:

- Multipara

- Pre-existing cancer (except non-melanoma skin cancer)

- Family history of breast cancer (one first-degree female relative diagnosed with breast cancer)

- High-risk pregnancy according to national guidelines

- During the follow-up, pregnant women under any treatment that may affect the levels of metabolic markers will be excluded from the analysis

- Pregnant women with pre-eclampsia or with preterm birth (less than 37 weeks of gestational age) will be also excluded

Резултат

Първични изходни мерки

1. Breast absolute fibro-glandular volume (AFGV) measured by DXA technique [Three months after breastfeeding cessation]

cm3 and tertiles of their distribution estimated by DXA technique

2. Breast percentage of fibro-glandular volume (%FVG) measured by DXA technique [Three months after breastfeeding cessation]

percentage and tertiles of their distribution estimated by DXA technique

Присъединете се към нашата
страница във facebook

Най-пълната база данни за лечебни билки, подкрепена от науката

  • Работи на 55 езика
  • Билкови лекове, подкрепени от науката
  • Разпознаване на билки по изображение
  • Интерактивна GPS карта - маркирайте билките на място (очаквайте скоро)
  • Прочетете научни публикации, свързани с вашето търсене
  • Търсете лечебни билки по техните ефекти
  • Организирайте вашите интереси и бъдете в крак с научните статии, клиничните изследвания и патентите

Въведете симптом или болест и прочетете за билките, които биха могли да помогнат, напишете билка и вижте болестите и симптомите, срещу които се използва.
* Цялата информация се базира на публикувани научни изследвания

Google Play badgeApp Store badge